Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 9/2016

Open Access 01-09-2016 | Laryngology

Long-term follow-up after surgery in localized laryngeal amyloidosis

Authors: Aldert J. C. Hazenberg, Bouke P. C. Hazenberg, Frederik G. Dikkers

Published in: European Archives of Oto-Rhino-Laryngology | Issue 9/2016

Login to get access

Abstract

To study effectiveness of surgery and watchful waiting in localized laryngeal amyloidosis, retrospective case series. This retrospective study comprises all consecutive patients with localized laryngeal amyloidosis surgically treated in a tertiary hospital between 1994 and February 2016. Recurrence rate, revision surgery, progression to systemic amyloidosis, and changes in voice were monitored yearly. Eighteen patients were included. Seven women and eleven men had a median age 50 years (range 21–77 years) and median follow-up 6.4 years (2.4–17 years). Amyloid was located in subglottis (5), glottis (8), false vocal folds (8) and other supraglottic areas (5), in more than one laryngeal region (13) and bilaterally (12). Cold steel excision was used at the glottis; CO2 laser excision, sometimes assisted by microdebrider, at other laryngeal areas. Eleven patients needed revision surgery, ten within the first 4 years after surgical treatment. One patient needed his first revision surgery after 11 years. Five patients needed a second revision within 6 years after initial diagnosis. Two patients needed a third revision. Indications for first revision surgery were progression (8) with dysphonia (7), dyspnea (2), dysphagia (1), exclusion of malignancy (1), and aphonia (1). No patient developed systemic amyloidosis during follow-up. Although local progression of amyloid necessitates revision surgery once or twice in the first 4–6 years, progression slows down thereafter. Late progression, however, remains possible.
Literature
2.
go back to reference Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P (2014) Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21:221–224CrossRefPubMed Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P (2014) Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21:221–224CrossRefPubMed
3.
go back to reference Bartels H, Dikkers FG, van der Wal JE, Lokhorst HM, Hazenberg BP (2004) Laryngeal amyloidosis: localized versus systemic disease and update on diagnosis and therapy. Ann Otol Rhinol Laryngol 113:741–748CrossRefPubMed Bartels H, Dikkers FG, van der Wal JE, Lokhorst HM, Hazenberg BP (2004) Laryngeal amyloidosis: localized versus systemic disease and update on diagnosis and therapy. Ann Otol Rhinol Laryngol 113:741–748CrossRefPubMed
4.
go back to reference Gilad R, Milillo P, Som PM (2007) Severe diffuse systemic amyloidosis with involvement of the pharynx, larynx, and trachea: CT and MR findings. Am J Neuroradiol 28:1557–1558CrossRefPubMed Gilad R, Milillo P, Som PM (2007) Severe diffuse systemic amyloidosis with involvement of the pharynx, larynx, and trachea: CT and MR findings. Am J Neuroradiol 28:1557–1558CrossRefPubMed
5.
go back to reference Hazenberg AJ, Dikkers FG, Hawkins PN et al (2009) Laryngeal presentation of systemic apolipoprotein A-I-derived amyloidosis. Laryngoscope. 119:608–615CrossRefPubMed Hazenberg AJ, Dikkers FG, Hawkins PN et al (2009) Laryngeal presentation of systemic apolipoprotein A-I-derived amyloidosis. Laryngoscope. 119:608–615CrossRefPubMed
6.
go back to reference Motta G, Salzano FA, Motta S, Staibano S (2003) CO2 laser treatment of laryngeal amyloidosis. J Laryngol Otol 117:647–650CrossRefPubMed Motta G, Salzano FA, Motta S, Staibano S (2003) CO2 laser treatment of laryngeal amyloidosis. J Laryngol Otol 117:647–650CrossRefPubMed
7.
go back to reference Walker PA, Courey MS, Ossoff RH (1996) Staged endoscopic treatment of laryngeal amyloidosis. Otolaryngol Head Neck Surg 114:801–805CrossRefPubMed Walker PA, Courey MS, Ossoff RH (1996) Staged endoscopic treatment of laryngeal amyloidosis. Otolaryngol Head Neck Surg 114:801–805CrossRefPubMed
8.
go back to reference Paccalin M, Hachulla E, Cazalet C et al (2005) Localized amyloidosis: a survey of 35 French cases. Amyloid 12:239–245CrossRefPubMed Paccalin M, Hachulla E, Cazalet C et al (2005) Localized amyloidosis: a survey of 35 French cases. Amyloid 12:239–245CrossRefPubMed
9.
10.
go back to reference Kennedy TL, Patel NM (2000) Surgical management of localized amyloidosis. Laryngoscope 110:918–923CrossRefPubMed Kennedy TL, Patel NM (2000) Surgical management of localized amyloidosis. Laryngoscope 110:918–923CrossRefPubMed
11.
go back to reference Thompson LD, Derringer GA, Wenig BM (2000) Amyloidosis of the larynx: a clinicopathologic study of 11 cases. Mod Pathol 13:528–535CrossRefPubMed Thompson LD, Derringer GA, Wenig BM (2000) Amyloidosis of the larynx: a clinicopathologic study of 11 cases. Mod Pathol 13:528–535CrossRefPubMed
12.
go back to reference Piazza C, Cavaliere S, Foccoli P, Toninelli C, Bolzoni A, Peretti G (2003) Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients. Eur Arch Otorhinolaryngol 260:349–354CrossRefPubMed Piazza C, Cavaliere S, Foccoli P, Toninelli C, Bolzoni A, Peretti G (2003) Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients. Eur Arch Otorhinolaryngol 260:349–354CrossRefPubMed
13.
go back to reference Neuner GA, Badros AA, Meyer TK, Nanaji NM, Regine WF (2012) Complete resolution of laryngeal amyloidosis with radiation treatment. Head Neck 34:748–752CrossRefPubMed Neuner GA, Badros AA, Meyer TK, Nanaji NM, Regine WF (2012) Complete resolution of laryngeal amyloidosis with radiation treatment. Head Neck 34:748–752CrossRefPubMed
14.
go back to reference Truong MT, Kachnic LA, Grillone GA et al (2012) Long-term results of conformal radiotherapy for progressive airway amyloidosis. Int J Radiat Oncol Biol Phys 83:734–739CrossRefPubMed Truong MT, Kachnic LA, Grillone GA et al (2012) Long-term results of conformal radiotherapy for progressive airway amyloidosis. Int J Radiat Oncol Biol Phys 83:734–739CrossRefPubMed
15.
16.
go back to reference De Bodt M, Wuyts FL, Van de Heyning PH, Croux C (1997) Test-retest study of the GRBAS scale: influence of experience and professional background on perceptual rating of voice quality. J Voice 11:74CrossRefPubMed De Bodt M, Wuyts FL, Van de Heyning PH, Croux C (1997) Test-retest study of the GRBAS scale: influence of experience and professional background on perceptual rating of voice quality. J Voice 11:74CrossRefPubMed
17.
go back to reference Bouwers F, Dikkers FG (2009) A retrospective study concerning the psychosocial impact of voice disorders: voice Handicap Index change in patients with benign voice disorders after treatment (measured with the Dutch version of the VHI). J Voice 23:218–224CrossRefPubMed Bouwers F, Dikkers FG (2009) A retrospective study concerning the psychosocial impact of voice disorders: voice Handicap Index change in patients with benign voice disorders after treatment (measured with the Dutch version of the VHI). J Voice 23:218–224CrossRefPubMed
18.
go back to reference Hazenberg BP, van Rijswijk MH, Piers DA et al (2006) Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 119:355 (e15–24) CrossRefPubMed Hazenberg BP, van Rijswijk MH, Piers DA et al (2006) Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 119:355 (e15–24) CrossRefPubMed
19.
go back to reference Ma L, Bandarchi B, Sasaki C, Levine S, Choi Y (2005) Primary localized laryngeal amyloidosis: report of 3 cases with long-term follow-up and review of the literature. Arch Pathol Lab Med 129:215–218PubMed Ma L, Bandarchi B, Sasaki C, Levine S, Choi Y (2005) Primary localized laryngeal amyloidosis: report of 3 cases with long-term follow-up and review of the literature. Arch Pathol Lab Med 129:215–218PubMed
20.
go back to reference Alaani A, Warfield AT, Pracy JP (2004) Management of laryngeal amyloidosis. J Laryngol Otol 118:279–283PubMed Alaani A, Warfield AT, Pracy JP (2004) Management of laryngeal amyloidosis. J Laryngol Otol 118:279–283PubMed
22.
go back to reference Wierzbicka M, Budzyudzy D, Piwowarczyk K, Bartochowska A, Marszarsz A, Szyfter W (2012) How to deal with laryngeal amyloidosis? Experience based on 16 cases. Amyloid. 19:177–181CrossRefPubMed Wierzbicka M, Budzyudzy D, Piwowarczyk K, Bartochowska A, Marszarsz A, Szyfter W (2012) How to deal with laryngeal amyloidosis? Experience based on 16 cases. Amyloid. 19:177–181CrossRefPubMed
23.
go back to reference Pribitkin E, Friedman O, O’Hara B et al (2003) Amyloidosis of the upper aerodigestive tract. Laryngoscope 113:2095–2101CrossRefPubMed Pribitkin E, Friedman O, O’Hara B et al (2003) Amyloidosis of the upper aerodigestive tract. Laryngoscope 113:2095–2101CrossRefPubMed
24.
go back to reference Mäkitie AA, Vala U, Kronlund H, Kääriäinen M, Pettersson T (2013) Laryngeal amyloidosis as a cause of death. Amyloid 20:58CrossRefPubMed Mäkitie AA, Vala U, Kronlund H, Kääriäinen M, Pettersson T (2013) Laryngeal amyloidosis as a cause of death. Amyloid 20:58CrossRefPubMed
Metadata
Title
Long-term follow-up after surgery in localized laryngeal amyloidosis
Authors
Aldert J. C. Hazenberg
Bouke P. C. Hazenberg
Frederik G. Dikkers
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 9/2016
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-4061-y

Other articles of this Issue 9/2016

European Archives of Oto-Rhino-Laryngology 9/2016 Go to the issue